Bilstraat 106

3572 BJ, Utrecht, the Netherlands

info@virology-education.com

  • White Twitter Icon
  • White LinkedIn Icon
  • White Facebook Icon

Tel: +31 (0)30 230 7140
Fax: +31 (0)30 230 7148

© 2019 by Virology Education

International Workshop on HIV & Aging 2019
HIV aging highlight 1 Charles.jpg
HIV aging highlight 2 Julian.jpg
HIV aging highlight 3 Scott.jpg

 

Format: Online Course

Publish Date: 5 November 2019 

 

Expiry Date: 5 November 2020 

FACULTY 

Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
 

Julian Falutz, MD, FRCP
McGill University, Canada

Scott Letendre, MD
University of California, United States

The longer life expectancy of people with HIV infection is changing the demographics of the HIV epidemic and currently, more than one-half of the people living with HIV are age 45 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, with a greater burden of comorbidities and the associated treatments. In comparison to similar HIV-uninfected populations, HIV-infected persons, even when on effective ART, experience an excess of morbidity and mortality. 

With an aging HIV population, there is a pressing need for substantive scientific dialog on this topic, particularly since HIV itself may accelerate the aging process. The multidisciplinary nature of HIV and aging requires linking expertise in many areas including geriatrics, internal medicine, HIV, pharmacology, psychology, and numerous subspecialties. The highlights cover the International Workshop on HIV & Aging in its tenth anniversary, initiated in 2009 as a unique and much-needed platform for scientific exchange on the increasingly recognized difficulties encountered in the clinical care and design of research studies to improve the care of persons aging with HIV. 

This year’s highlights faculty Dr. Charles Flexner, Dr. Julian Falutz, and Dr. Scott Letendre will cover the most notable topics, data and research presented at the meeting and cover the latest findings on HIV, Aging in the international setting, Aging and lung function, Aging and non-HIV cancers, Aging, muscle function and exercise, Aging and HIV cure, Aging and Frailty, Influences of future morbidity burden, Altered coagulation as a pathophysiological mechanism, New models of care for PLWH, Cannabis use among older adults and Health effects of cannabis and cannabinoids.

LEARNING OBJECTIVES

 
After participating in the full program ( three modules ), you will be able to: 
•Identify age-related clinical complications found in older people living with HIV
• Integrate the latest scientific research into daily clinical care to improve the quality of life of these people
• Identify the future challenges faced by this expanding population of older people living with HIVs.

NEEDS ASSESSMENT

 
The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. Persons on ART rarely die from complications of AIDS, but instead have early onset of aging complications including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. 

The high priority on understanding the interaction between age and HIV infection is illustrated by recent summary reports from the HIV and Aging Consensus Project in the Journal of the American Geriatrics Society and ongoing NIH Program Announcements in “Multidisciplinary Studies of HIV/AIDS and Aging”, in addition to strong voices in the community.


Improved management of older adults with HIV will require a much deeper understanding of the interface between aging, HIV, associated comorbid conditions, and concurrent treatment. In addition, research is needed to address the unique psychosocial challenges faced by this growing population.


Improved management of older adults with HIV will require a much deeper understanding of the interface between aging, HIV, associated comorbid conditions, and concurrent treatment. In addition, research is needed to address the unique psychosocial challenges faced by this growing population.

ACKNOWLEDGEMENTS

Provided by Virology Education.

This activity has been made possible by an unrestricted educational grant from ViiV Healthcare.